Abstract
Purpose. The aim of this study was to assess in vivo which organs contribute to the first-pass metabolism of diltiazem.
Methods. Anaesthetized rabbits received diltiazem into the thoracic aorta (TA) (1 mg/kg), jugular vein (JV) (2 mg/kg), portal vein (PV) (4 mg/kg) or small intestine (SI) (5 mg/kg). Serial blood samples were withdrawn from the abdominal aorta to assay diltiazem, N-demethyl-diltiazem (MA) and deacetyldiltiazem (M1).
Results. The area under diltiazem plasma concentration curve/time (AUC0−∞) normalized by the dose was AUCTA ≈ AUCJV > AUCPV > AUCSI. Intestinal and hepatic diltiazem availability was 43 and 33%, respectively. The systemic availability of oral diltiazem was 12%. Diltiazem given into the SI and PV generated primarily MA, and injected into the JV and TA produced mainly Ml.
Conclusions. In rabbits, the intestine and the liver contribute to the first-pass metabolism of diltiazem, and the amount and species of metabolites generated depend upon the route of administration of diltiazem.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
M.M.T. Buckley, S. Grant, K.L. Goa, D. McTavish and E.M. Sorkin. Diltiazem; a reappraisal of its pharmacological properties and therapeutic use. Drugs 39:757–806 (1990).
M.S. Smith, C.P. Verghese, D.G. Shand and E.L.C. Pritchet. Pharmacokinetic and pharmacodynamic effects of diltiazem. Am. J. Cardiol. 51:1369–1374 (1983).
P.K.F. Yeung, S.J. Mosher, M.A. Quillam and T.J. Montague. Species comparison of pharmacokinetics and metabolism of diltiazem in humans, dogs, rabbits and rats. Drug Metab. Dispos. 18:1055–1059 (1990).
P.K.F. Yeung, S.J. Mosher and P.T. Pollak. Pharmacokinetics and metabolism of diltiazem in rabbits after a single intravenous or single oral administration. Eur. J. Drug Metab. Pharmacokin. 16:69–74 (1991).
J. Sugihara, Y. Sugawara, H. Ando, S. Harigaya, A. Etoh and K. Kohno. Studies on the metabolism of diltiazem in man. J. Pharmacobiodyn. 7:24–32 (1984).
J.R. Bend and C.J. Serabjit-Singh. Xenobiotic metabolism by extrahepatic tissues: relationship to target organ and cell toxicity, In JR. Mitchell and MG. Horning (eds.), Drug Metabolism and Drug Toxicity, Raven Press, New York, 1984, pp. 99–136.
M. Mistry and J.B. Houston. Quantitation of extrahepatic metabolism. Drug Metab. Dispos. 13:740–745 (1985).
H. Vainio and E. Hietanen. Role of extrahepatic metabolism in drug disposition and toxicity. In P. Jenner and B. Testa (eds.), Concepts in Drug Metabolism, part A, Marcel Dekker, New York, 1980, pp. 251–284.
M.K. Cassidy and J.B. Houston. In vivo capacity of hepatic and extrahepatic enzymes to conjugate phenol. Drug Metab. Dispos. 12:619–624 (1984).
L. Pichard, G. Gillet, I. Fabre, I. Dalet-Beluche, C. Bonfils, J.P. Thenot and P. Maurel. Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem. Drug Metab. Dispos. 18:711–719 (1990).
D.R. Krishna and U. Klotz. Extrahepatic metabolism of drugs in humans. Clin. Pharmacokin. 26:144–160 (1994).
G. Caillé, L. Dubé, Y. Théorêt, F. Varin, N. Mousseau and I. McGilveray. Stability study of diltiazem and two of its metabolites using a high performance liquid chromatographic method. Biopharm. Drug Dispos. 10:107–114 (1989).
K.F. Ilett, L.B.G. Tee, P.T. Reeves and R.F. Minchin. Metabolism of drugs and other xenobiotics in the gut lumen and wall. Pharmac. Ther. 46:67–93 (1990).
A.S.J. Koster, G.A. Hofman, A.C. Frankhuijzen-Sierevogel and J. Noordhoek. Presystemic and systemic intestinal metabolism of fenoterol in the conscious rat. Drug Metab. Dispos. 13:464–470 (1985).
S. Perreault, L. Dumont, V. Villière, H. Ong, A. Adam and P. du Souich. Hepatic and extrahepatic metabolism of salbutamol in anesthetized rabbits. Drug Metab. Dispos. 21:485–491 (1993).
G.M. Pacifici, M. Franchi, P.G. Gervasi, V. Longo, P. di Simplico, A. Temellini, and L. Giuliani. Profile of drug-metabolizing enzymes in human ileum and colon. Pharmacology 38:137–145 (1989).
W. Homsy, M. Lefebvre, G. Caillé and P. du Souich. Metabolism of diltiazem in hepatic and extrahepatic tissues of rabbits: in vitro studies. Pharmac. Res. 12:609–614 (1995).
D.M. Geddes, K. Nesbitt, T. Trail and J.P. Blackburn. First-pass uptake of 14C propranolol by the lung. Thorax 34:810–813 (1979).
D.L. Roerig, K.J. Kotrly, E.J. Vucins, S.B. Ahlf, C.A. Dawson, and J.P. Kampine. First-pass uptake of fentanyl, meperidine and morphine in the human lung. Anesthesiology 67:466–472 (1987).
A.G.E. Wilson, R.D. Pickett, T.E. Eling and M.W. Anderson. Studies on the persistence of basic amines in the rabbit lung. Drug Metab. Dispos. 7:420–424 (1979).
U.S. Ryan and C.J. Grantham. Metabolism of endogenous and xenobiotic substances by pulmonary vascular endothelial cells. Pharmac. Ther. 42:235–250 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lefebvre, M., Homsy, W., Caillé, G. et al. First-Pass Metabolism of Diltiazem in Anesthetized Rabbits: Role of Extrahepatic Organs. Pharm Res 13, 124–128 (1996). https://doi.org/10.1023/A:1016097805003
Issue Date:
DOI: https://doi.org/10.1023/A:1016097805003